2nd International
Brain Technology Conference

March 11-12, Hangar 11, Tel Aviv Port, Israel

Moussa B.H. Youdim, PhD

Founder, CSO , President & Chairman, Abital Pharma Pipelines

Moussa

Prof. Moussa Youdim was chairman of Pharmacology from its inception from 1977 to 1994. He was the Finkelstein Professor of Life Sciences and Professor of Pharmacology   at the Technion- Rappaport Family Faculty of Medicine . He is Professor Emeritus and  the Director of the Eve Topf  and National Parkinson Foundation (USA) Centers of Excellence for Neurodegenerative Diseases Research and Teaching at Technion. He holds the position of Honorary Professor and Distinguished Chair Professor  at Hong Kong and PolyTechnic Universities in Hong Kong,  Yonsei World Central University in Seoul , South Korea,;Qingdao University and Shanghai University of Chinese Traditional Medicine in Chinaand Janin University in China.

He  is  internationally renowned for his research in on monoamine oxidsaes , brain iron metabolism, Parkinson’s disease (PD) ,Alzheimer’s disease (AD), amyotrophic lateral sclerosis and drug development for these disorders and for establishing the importance of  monoamine oxidase and brain iron metabolism for brain function and dysfunction. His  research at Oxford University  led to the discovery of  the first  monoamine  oxidase B inhibitor, l-deprenyl (selegiline) as an anti Parkinson drug in 1975 and the concept of neuroprotection and  at Technion the development of the  second generation  of neuroprotective monoamine oxidase  B inhibitor anti-Parkinson drug, Rasagiline (Azilect). He developed  the multifunctional  neuroprotective   anti-Alzheimer drug, currently designated Ladostigil ( TV 3326),  which has recently shown positive results in Phase IIb double blind control clinical studies in Alzheimer patients and novel multi target  neurorestorative M30 iron chelator series which are under development for Parkinson’s and Alzheimer’s  diseases in his company Abital Pharma Pipeline.

He has published more than 900 scientific articles and edited 45 books and  has been on the Editorial Board of 43 International scientific journals.  He  has received  numerous (40) major international prizes, awards and honours from Iran (Homayoon Medal fron Shah of Iran),  Israel, U.S., England, Germany, Iran, Denmark,  Holland and Switzerland, including two Honoary Doctorate of Philosophy, Honory Causa, from universities of  Semmelweis University (Hungry)  and Pisa (Italy).).  From 1991 through 1999, he was a Fogarty International Scholar-in-Residence at the Fogarty International Center for Advanced Study in the Human Health Sciences program of the National Institute of Health in Bethesda, USA. He is the Scientific founder Varinel Inc and Varinel LCD (USA)  Cardiamit,  Avraham Pharmaceutical (Israel) and Chief Scientific Officer og Abital Pharma Pipeline Ltd. (Israel). He is an elected member of  Leopoldina German Academy of Sciences, the oldest academy in the world .He  was recently awarded ECNP (European College of Neuropsychopharamacolgy ) Lifetime Achievement Award , the EMET prize for brain science from Israel, CINP (International College of Neuropschopharmacology) Pioneering Award and the Arvid Carlson Metal and The Catecholamine Pioneering Award from NIH and 10th International Congress of Catecholamine.